Imatinib

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Imatinib and local guidelines before prescribing.

Tyrosine kinase inhibitor

Mechanism

BCR-ABL tyrosine kinase inhibitor.

Uses

Chronic myeloid leukaemia, GIST, Ph-positive ALL.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Fluid retention, nausea, muscle cramps, rash, myelosuppression, hepatotoxicity.

Interactions

CYP3A4 inhibitors raise levels; inducers reduce levels; warfarin interaction.

Contraindications and cautions

Severe liver impairment

Monitoring

FBC, LFT, BCR-ABL PCR

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Reduce dose in renal and hepatic impairment

Overdose and reversal

Supportive

Special advice

Take with food; molecular monitoring (BCR-ABL); weight and oedema.

More from the textbook: uses, cautions and other points
Where it is discussed in the book